Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide, Metformin, and Insulin Effects on Par-4 and Telomeres in Type 2 Diabetes
NCT02535299Phase 4Unknown
- Sponsor
- Army Medical University
- Start
- Jun 2016
- Primary completion
- Dec 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Army Medical University. Status: unknown.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02535299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02535299.